Assorted Color Kittens

Toltramax: Transforming the Future of Companion Animal Health

The global pet care industry is ever-evolving, necessitating innovative and safe solutions for managing animal health. Toltramax, a pioneering brand of toltrazuril, is set to transform how veterinarians manage parasitic infections in non-food chain animals such as dogs, cats, and horses. Recognized as the safest solution on the market, Toltramax is making significant strides in improving companion animal health, productivity, and overall well-being.


Amazon Prime Day 2024 Projects $14 Billion Profit, Data Analytics Say

With Amazon’s Prime Day merely hours away, Adobe Analytics data is expecting that the retailer would receive a $14 billion paycheck.

UK's Electoral Commission Reveals Labour's Nearly Fivefold Donation Increase After Election Win

The UK’s Electoral Commission revealed that the Labour Party, which won a landslide victory in this month’s general election, received almost five times as much campaign donation money as the Conservative Party.

Fruit Ninja Makes Slashing Debut on Nex Playground

The motion-based gaming console Nex Playground announced that the famous Halfbrick game Fruit Ninja is coming to the platform.


Latest News

Thailand Announces $13.8 Billion 'Digital Wallet' Stimulus Plan to Revive Economy
Thailand's Prime Minister Srettha Thavisin announced a $13.8 billion digital cash handout program, the "Digital Wallet," aiming to revive the economy by distributing $275 each to 50 million citizens to stimulate local businesses, starting in August.
Luxury Giant Burberry Suspends Dividend and Appoints New CEO as Shares Drop Sharply
Burberry faces leadership changes and a profit warning as sharp stock declines amid ongoing sales drops and forecasted financial losses.
Chinese Carbon Tech Firm XDS Invests on Mark Cavendish’s Cycling Team Astana Qazaqstan
Chinese carbon bicycle technology manufacturer XDS confirmed Monday (July 15) that it will invest in the professional cycling team Astana Qazaqstan.
Gun and Prison Stocks Gain as Trump’s Election Odds Improve Post-Rally Incident
Following an assassination attempt at a Donald Trump rally, cryptocurrency, gun, and prison stocks surged in premarket trading on Monday, with Trump Media & Technology Group up 67%.
How to Get Student Discount on Amazon Prime + 6 Months Free Trial
A step-by-step guide on how to get the Amazon Prime Student discount with an initial six-month free trial.
University of Oxford
Oxford Vacmedix, a spinout from Oxford University, is at the forefront of developing therapeutic cancer vaccines. Their innovative technology, based on Recombinant Overlapping Peptides (ROP), aims to harness the body's immune system to fight existing cancer in patients.
Kenneth W. Welch Jr.'s 'Global Corporate Machine': A Revolutionary Blueprint to Benefit Humanity and Heal the Planet
In an era plagued by climate crises, social inequality, and economic uncertainty, visionary entrepreneur Kenneth W. Welch Jr. is rewriting the rules of corporate responsibility. His brainchild, "Global's Corporate Machine," a groundbreaking model blending business acumen with humanitarian aims to tackle the world's most pressing growth, development, economic, and detrimental challenges holding back or plaguing our "Planet, Head-on."
Westlake Village Headshots
NeOnc, Technologies Holdings, Inc., a biotech company revolutionizing the treatment of brain cancer with its innovative delivery method, is breaking new ground once again by closing its most recent funding round at a $220 million valuation.
Billon
Our world is increasingly more digital, which means that security and data integrity are non-negotiable. Billon specializes in high-performance, regulatory-compliant blockchain technology for digital cash, documents on-chain, data, and identity management. Their advanced Distributed Ledger Technology (DLT) transforms how data is exchanged securely and transparently.
Dr. Jonathan Kaplan
The market for GLP-1 (glucagon-like peptide-1) receptor agonists is quickly becoming a profitable investment option. Despite these medications' promising efficacy and expanding indications, the market faces significant challenges that need innovative solutions. Dr. Jonathan Kaplan, a renowned plastic surgeon and entrepreneur, has strategically positioned his company, BuildMyHealth, to tackle these obstacles and take advantage of the vast opportunities in the GLP-1 market.
  20 21 22 23 24 25 26 27 28